Page 158 - HIV/AIDS Guidelines

19. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the prevention and treatment of
opportunistic infections in adults and adolescents with HIV/AIDS. Department of Health and Human Services. 2012 (In
Press).
20. Soriano V, et al. Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the
HCV-HIV International Panel. AIDS. 2007;21(9):1073-1089.
21. Tien PC. Management and treatment of hepatitis C virus infection in HIV-infected adults: recommendations from the
Veterans Affairs Hepatitis C Resource Center Program and National Hepatitis C Program Office. Am J Gastroenterol.
2005;100(10):2338-2354.
22. Avidan NU, et al. Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients
as a Function of Baseline CD4+ T-Cell Counts. J Acquir Immune Defic Syndr. 2009;52(4):452-458.
23. Sulkowski MS, et al. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults. AIDS. 2007;21(16):
2209-2216.
24. Brau N, et al. Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using
antiretroviral therapy. J Hepatol. 2006;44(1):47-55.
25. Macias J, et al. Fast fibrosis progression between repeated liver biopsies in patients coinfected with human
immunodeficiency virus/hepatitis C virus. Hepatology. 2009;50(4):1056-1063.
26. Verma S, Goldin RD, Main J. Hepatic steatosis in patients with HIV-Hepatitis C Virus coinfection: is it associated with
antiretroviral therapy and more advanced hepatic fibrosis? BMC Res Notes. 2008;1:46.

27. Ragni MV, et al. Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infection.
Haemophilia. 2009;15(2):552-558.

28. Aranzabal L, et al. Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients
with HIV and hepatitis C virus coinfection. Clin Infect Dis. 2005;40(4):588-593.

29. Labarga P, et al. Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-
infected patients. J Infect Dis. 2007;196(5):670-676.

30. Nunez M. Hepatotoxicity of antiretrovirals: incidence, mechanisms and management. J Hepatol. 2006;44(1 Suppl):S132-
S139.
31. McGovern BH, et al. Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus
genotype 3 infection in HIV-seropositive patients. Clin Infect Dis. 2006;43(3):365-372.
32. Kovari H, et al. Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with
didanosine: a nested case-control study. Clin Infect Dis. 2009;49(4):626-635.
33. Food and Drug Administration. Aptivus (package insert). http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/
021814s011lbl.pdf. Accessed March 26, 2012.
34. Sulkowski MS, Thomas DL. Hepatitis C in the HIV-infected patient. Clin Liver Dis. 2003;7(1):179-194.

35. Fleischer R, Boxwell D, Sherman KE. Nucleoside analogues and mitochondrial toxicity. Clin Infect Dis. 2004;38(8):e79-
e80.
36. Alvarez D, et al. Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-
infected persons. J Viral Hepat. 2006;13(10):683-689.
37. Vispo E, et al. Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C
treated with abacavir. Antivir Ther. 2008;13(3):429-437.
38. Laufer N, et al. Abacavir does not influence the rate of virological response in HIV-HCV-coinfected patients treated with
pegylated interferon and weight-adjusted ribavirin. Antivir Ther. 2008;13(7):953-957.
39. Mira JA, et al. Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients
receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue
backbone. J Antimicrob Chemother. 2008;62(6):1365-1373.
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents J-10

Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.